167221-71-8 | 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester

Packsize	Purity	Availability	Price	Discounted Price
10mg	97%	in stock	$15.00	$10.00
25mg	97%	in stock	$18.00	$12.00
50mg	97%	in stock	$22.00	$15.00
100mg	97%	in stock	$33.00	$23.00
250mg	97%	in stock	$48.00	$33.00
1g	97%	in stock	$62.00	$44.00
5g	97%	in stock	$182.00	$127.00
25g	97%	in stock	$651.00	$456.00

Description

• Catalog Number: AA88865
• Chemical Name: 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
• CAS Number: 167221-71-8
• Molecular Formula: C21H23Cl2NO6
• Molecular Weight: 456.3164
• MDL Number: MFCD00940070
• SMILES: CCCC(=O)OCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1Cl)Cl)C(=O)OC)C

Computed Properties

• Complexity: 748
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 10
• Undefined Atom Stereocenter Count: 1
• XLogP3: 4.3

Literature

• Differential modulation of FXR activity by chlorophacinone and ivermectin analogs.

  Toxicology and applied pharmacology 20161215

• Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.

  European journal of clinical pharmacology 20121001

• Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.

  Journal of cardiothoracic and vascular anesthesia 20120601

• Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting.

  American journal of therapeutics 20120501

• Clevidipine : a state-of-the-art antihypertensive drug under the scope.

  Expert opinion on pharmacotherapy 20120201

• Clevidipine for controlled hypotension during spinal surgery in adolescents.

  Journal of neurosurgical anesthesiology 20111001

• Clevidipine for controlled hypotension during spinal surgery in adolescents.

  Middle East journal of anaesthesiology 20110601

• Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.

  Blood pressure. Supplement 20110401

• Perioperative blood pressure management: walking a tightrope.

  Annals of cardiac anaesthesia 20110101

• Cardiovascular pharmacology: an update.

  Anesthesiology clinics 20101201

• Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience.

  Journal of neurosurgical anesthesiology 20101001

• Use of clevidipine for intraoperative hypertension caused by an undiagnosed pheochromocytoma: a case report.

  AANA journal 20100801

• Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.

  Pharmacotherapy 20100501

• Clevidipine: a new intravenous option for the management of acute hypertension.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100301

• Clevidipine butyrate: a promising new drug for the management of acute hypertension.

  Expert opinion on pharmacotherapy 20100201

• Parenteral nutrition in the critically ill patient.

  The New England journal of medicine 20100107

• Clevidipine for the treatment of severe hypertension in adults.

  Clinical therapeutics 20100101

• Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis.

  Congestive heart failure (Greenwich, Conn.) 20100101

• Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review.

  Vascular health and risk management 20100101

• Preliminary experience with clevidipine in the pediatric population.

  Journal of intensive care medicine 20100101

• Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.

  Annals of emergency medicine 20090801

• A new intravenous calcium channel blocker option to treat acute elevations in blood pressure.

  Journal of clinical hypertension (Greenwich, Conn.) 20090701

• Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.

  The Annals of pharmacotherapy 20090701

• New drugs 09, part 2.

  Nursing 20090601

• Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.

  Expert review of cardiovascular therapy 20090501

• Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.

  Annals of emergency medicine 20090301

• Clevidipine: a review of its use in the management of acute hypertension.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101

• Clevidipine: a novel ultra-short-acting calcium antagonist.

  Cardiology in review 20090101

• Drug evaluation of clevidipine for acute hypertension.

  Expert opinion on pharmacotherapy 20081001

• The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.

  Anesthesia and analgesia 20081001

• Novel I.V. drug approved.

  Nursing 20081001

• Clevidipine (Cleviprex) for IV treatment of severe hypertension.

  The Medical letter on drugs and therapeutics 20080922

• FDA approves i.v. calcium-channel blocker.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080915

• Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial.

  Anesthesia and analgesia 20080701

• Perioperative hypertension management.

  Vascular health and risk management 20080601

• New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine.

  Journal of the American Pharmacists Association : JAPhA 20080101

• Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1.

  Anesthesia and analgesia 20071001

• New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker.

  Expert opinion on investigational drugs 20070901

• New drugs for hypertension: what do they offer?

  Current hypertension reports 20061001

• Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.

  Drug metabolism and disposition: the biological fate of chemicals 20060501

• Current diagnosis and management of hypertensive emergency.

  Seminars in dialysis 20060101

• Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.

  Journal of cardiovascular pharmacology 20041001

• Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.

  Cardiovascular drug reviews 20040101

• Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery.

  European journal of anaesthesiology 20030901

• Cardiac sympathetic nerve stimulation triggers coronary t-PA release.

  Arteriosclerosis, thrombosis, and vascular biology 20030601

• Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.

  Journal of cardiovascular pharmacology 20021001

• Clevidipine (the Medicines Company).

  Current opinion in investigational drugs (London, England : 2000) 20021001

• Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.

  Journal of cardiovascular pharmacology 20020901

• Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part I.

  Journal of cardiovascular pharmacology 20020801

• Clevidipine in adult cardiac surgical patients: a dose-finding study.

  Anesthesiology 20020501

• Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.

  Clinical and experimental hypertension (New York, N.Y. : 1993) 20020501

• Clevidipine.

  Drugs in R&D 20020101

• Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.

  Cardiovascular research 20010701

• Fast enantioselective separation of clevidipine and a dihydropyridine substituted acid by SFC on Chiralpak AD.

  Fresenius' journal of analytical chemistry 20010101

• Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.

  Chirality 20010101